Balbir-Gurman A, Schapira D, Nahir A M
The B Shine Department of Rheumatology, Rambam Medical Center, Haifa, Israel.
Lupus. 1999;8(2):164-7. doi: 10.1191/096120399678847542.
A patient with systemic lupus erythematosus (SLE) developed primary subcutaneous nocardiosis during steroid and cyclophosphamide therapy for diffuse proliferative glomerulonephritis. In spite of local process the patient manifested signs of general deterioration mimicking SLE exacerbation. The diagnosis was made by bacteriologic examination of the material obtained by CT guided aspiration. Surgical drainage and systemic treatment with trimethoprim/sulphamethoxazole (TMT/SMZ) 960 mg twice/d led to a clinical recovery and enabled the continuation of the steroid and cytotoxic regimen.
一名系统性红斑狼疮(SLE)患者在接受类固醇和环磷酰胺治疗弥漫性增殖性肾小球肾炎期间发生了原发性皮下诺卡菌病。尽管是局部病变,但患者出现了全身状况恶化的体征,类似SLE病情加重。通过CT引导下穿刺获取的材料进行细菌学检查做出了诊断。手术引流并使用甲氧苄啶/磺胺甲恶唑(TMT/SMZ)960毫克每日两次进行全身治疗,使患者临床康复,并得以继续使用类固醇和细胞毒性药物治疗方案。